1543 related articles for article (PubMed ID: 33707411)
1. Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers.
Danlos FX; Grajeda-Iglesias C; Durand S; Sauvat A; Roumier M; Cantin D; Colomba E; Rohmer J; Pommeret F; Baciarello G; Willekens C; Vasse M; Griscelli F; Fahrner JE; Goubet AG; Dubuisson A; Derosa L; Nirmalathasan N; Bredel D; Mouraud S; Pradon C; Stoclin A; Rozenberg F; Duchemin J; Jourdi G; Ellouze S; Levavasseur F; Albigès L; Soria JC; Barlesi F; Solary E; André F; Pène F; Ackerman F; Mouthon L; Zitvogel L; Marabelle A; Michot JM; Fontenay M; Kroemer G
Cell Death Dis; 2021 Mar; 12(3):258. PubMed ID: 33707411
[TBL] [Abstract][Full Text] [Related]
2. Metabolomics study of COVID-19 patients in four different clinical stages.
Valdés A; Moreno LO; Rello SR; Orduña A; Bernardo D; Cifuentes A
Sci Rep; 2022 Jan; 12(1):1650. PubMed ID: 35102215
[TBL] [Abstract][Full Text] [Related]
3. Metabolic predictors of COVID-19 mortality and severity: a survival analysis.
Abdallah AM; Doudin A; Sulaiman TO; Jamil O; Arif R; Sada FA; Yassine HM; Elrayess MA; Elzouki AN; Emara MM; Thillaiappan NB; Cyprian FS
Front Immunol; 2024; 15():1353903. PubMed ID: 38799469
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab.
Meoni G; Ghini V; Maggi L; Vignoli A; Mazzoni A; Salvati L; Capone M; Vanni A; Tenori L; Fontanari P; Lavorini F; Peris A; Bartoloni A; Liotta F; Cosmi L; Luchinat C; Annunziato F; Turano P
PLoS Pathog; 2021 Feb; 17(2):e1009243. PubMed ID: 33524041
[TBL] [Abstract][Full Text] [Related]
5. Circulating acetylated polyamines correlate with Covid-19 severity in cancer patients.
Bourgin M; Derosa L; Silva CAC; Goubet AG; Dubuisson A; Danlos FX; Grajeda-Iglesias C; Cerbone L; Geraud A; Laparra A; Aprahamian F; Nirmalathasan N; Madeo F; Zitvogel L; Kroemer G; Durand S
Aging (Albany NY); 2021 Sep; 13(17):20860-20885. PubMed ID: 34517343
[TBL] [Abstract][Full Text] [Related]
6. Metabolic Signatures Associated with Severity in Hospitalized COVID-19 Patients.
Marín-Corral J; Rodríguez-Morató J; Gomez-Gomez A; Pascual-Guardia S; Muñoz-Bermúdez R; Salazar-Degracia A; Pérez-Terán P; Restrepo MI; Khymenets O; Haro N; Masclans JR; Pozo OJ
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946479
[TBL] [Abstract][Full Text] [Related]
7. High serum IL-6 values increase the risk of mortality and the severity of pneumonia in patients diagnosed with COVID-19.
Guirao JJ; Cabrera CM; Jiménez N; Rincón L; Urra JM
Mol Immunol; 2020 Dec; 128():64-68. PubMed ID: 33075636
[TBL] [Abstract][Full Text] [Related]
8. The specific metabolome profiling of patients infected by SARS-COV-2 supports the key role of tryptophan-nicotinamide pathway and cytosine metabolism.
Blasco H; Bessy C; Plantier L; Lefevre A; Piver E; Bernard L; Marlet J; Stefic K; Benz-de Bretagne I; Cannet P; Lumbu H; Morel T; Boulard P; Andres CR; Vourc'h P; Hérault O; Guillon A; Emond P
Sci Rep; 2020 Oct; 10(1):16824. PubMed ID: 33033346
[TBL] [Abstract][Full Text] [Related]
9. Amino Acid Metabolism is Significantly Altered at the Time of Admission in Hospital for Severe COVID-19 Patients: Findings from Longitudinal Targeted Metabolomics Analysis.
Ansone L; Briviba M; Silamikelis I; Terentjeva A; Perkons I; Birzniece L; Rovite V; Rozentale B; Viksna L; Kolesova O; Klavins K; Klovins J
Microbiol Spectr; 2021 Dec; 9(3):e0033821. PubMed ID: 34878333
[TBL] [Abstract][Full Text] [Related]
10. Alterations in the Kynurenine-Tryptophan Pathway and Lipid Dysregulation Are Preserved Features of COVID-19 in Hemodialysis.
Schuller M; Oberhuber M; Prietl B; Zügner E; Prugger EM; Magnes C; Kirsch AH; Schmaldienst S; Pieber T; Brodmann M; Rosenkranz AR; Eller P; Eller K
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430566
[TBL] [Abstract][Full Text] [Related]
11. The Serum Metabolome of Moderate and Severe COVID-19 Patients Reflects Possible Liver Alterations Involving Carbon and Nitrogen Metabolism.
Caterino M; Costanzo M; Fedele R; Cevenini A; Gelzo M; Di Minno A; Andolfo I; Capasso M; Russo R; Annunziata A; Calabrese C; Fiorentino G; D'Abbraccio M; Dell'Isola C; Fusco FM; Parrella R; Fabbrocini G; Gentile I; Castaldo G; Ruoppolo M
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502454
[TBL] [Abstract][Full Text] [Related]
12. Saliva metabolomic profile of COVID-19 patients associates with disease severity.
Saheb Sharif-Askari N; Soares NC; Mohamed HA; Saheb Sharif-Askari F; Alsayed HAH; Al-Hroub H; Salameh L; Osman RS; Mahboub B; Hamid Q; Semreen MH; Halwani R
Metabolomics; 2022 Oct; 18(11):81. PubMed ID: 36271948
[TBL] [Abstract][Full Text] [Related]
13. Metabolite reanalysis revealed potential biomarkers for COVID-19: a potential link with immune response.
Chen X; Gu M; Li T; Sun Y
Future Microbiol; 2021 May; 16():577-588. PubMed ID: 33973485
[No Abstract] [Full Text] [Related]
14. Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity.
Sindelar M; Stancliffe E; Schwaiger-Haber M; Anbukumar DS; Adkins-Travis K; Goss CW; O'Halloran JA; Mudd PA; Liu WC; Albrecht RA; García-Sastre A; Shriver LP; Patti GJ
Cell Rep Med; 2021 Aug; 2(8):100369. PubMed ID: 34308390
[TBL] [Abstract][Full Text] [Related]
15. Untargeted plasma metabolomic fingerprinting highlights several biomarkers for the diagnosis and prognosis of coronavirus disease 19.
Occelli C; Guigonis JM; Lindenthal S; Cagnard A; Graslin F; Brglez V; Seitz-Polski B; Dellamonica J; Levraut J; Pourcher T
Front Med (Lausanne); 2022; 9():995069. PubMed ID: 36250098
[TBL] [Abstract][Full Text] [Related]
16. Metabolic profiling during COVID-19 infection in humans: Identification of potential biomarkers for occurrence, severity and outcomes using machine learning.
Elgedawy GA; Samir M; Elabd NS; Elsaid HH; Enar M; Salem RH; Montaser BA; AboShabaan HS; Seddik RM; El-Askaeri SM; Omar MM; Helal ML
PLoS One; 2024; 19(5):e0302977. PubMed ID: 38814977
[TBL] [Abstract][Full Text] [Related]
17. Urine metabolomics links dysregulation of the tryptophan-kynurenine pathway to inflammation and severity of COVID-19.
Dewulf JP; Martin M; Marie S; Oguz F; Belkhir L; De Greef J; Yombi JC; Wittebole X; Laterre PF; Jadoul M; Gatto L; Bommer GT; Morelle J
Sci Rep; 2022 Jun; 12(1):9959. PubMed ID: 35705608
[TBL] [Abstract][Full Text] [Related]
18. Serum neopterin levels in relation to mild and severe COVID-19.
Robertson J; Gostner JM; Nilsson S; Andersson LM; Fuchs D; Gisslen M
BMC Infect Dis; 2020 Dec; 20(1):942. PubMed ID: 33302893
[TBL] [Abstract][Full Text] [Related]
19. Integrated histopathological, lipidomic, and metabolomic profiles reveal mink is a useful animal model to mimic the pathogenicity of severe COVID-19 patients.
Song Z; Bao L; Deng W; Liu J; Ren E; Lv Q; Liu M; Qi F; Chen T; Deng R; Li F; Liu Y; Wei Q; Gao H; Yu P; Han Y; Zhao W; Zheng J; Liang X; Yang F; Qin C
Signal Transduct Target Ther; 2022 Jan; 7(1):29. PubMed ID: 35091528
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of the tryptophan metabolome in urine of patients with acute intermittent porphyria.
Gomez-Gomez A; Marcos J; Aguilera P; To-Figueras J; Pozo OJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():347-354. PubMed ID: 28666226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
